Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-18T16:38:56.719Z Has data issue: false hasContentIssue false
  • English
  • Français

Food and Drug Administration Approval of Use of Diphtheria andTetanus Toxoids and Acellular Pertussis Vaccine

Published online by Cambridge University Press:  21 June 2016

Elaine Larson
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments
Information
Infection Control & Hospital Epidemiology , Volume 13 , Issue 3 , March 1992 , pp. 171 - 172
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1992 

References

1. Immunization Practices Advisory Committee. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures-recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. 1991;40.Google Scholar
2. American Academy of Pediatrics. Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 1991.Google Scholar
3. Blumberg, DA, Mink, CM, Cherry, JD, et al. Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69 kilodalton outer membrane protein antibody. J Pediatr: 1990;117:46–51.CrossRefGoogle ScholarPubMed
4. Mortimer, EA, Kimura, M, Cherry, JD, et al. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. Am J Dis Child. 1990;144:899–904.Google ScholarPubMed